This Drug Could End H.I.V. Why Hasn’t It?

Photo of This Drug Could End H.I.V. Why Hasn’t It?
Facebook
VKontakte
share_fav

Truvada, a drug manufactured by Gilead Sciences, is taken once daily to prevent infection with H.I.V. It currently costs about $20,000 annually.

view The New York Times: Latest News
#science and technology
#centers for disease control and prevention
#lobbying and lobbyists
#acquired immune deficiency syndrome
#preventive medicine
#clinical trials
#medicine and health
#drugs pharmaceuticals
#research
#truvada drug